4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-004149
Chief Executive Officer sold 17,408 shares at an average $3.55 ($61,877)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2022-01-11 | Sale | −14,362 | $3.56 | $51,081 | 15,978 | D |
| Rawcliffe Adrian Chief Executive Officer | 2022-01-12 | Sale | −3,046 | $3.54 | $10,795 | 3,356 | D |
| Open-market sales · 17,408 sh · avg $3.55 · $61,877 | |||||||
Loading xslF345X03/tm221700-11_4seq.xml…